Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
With the approval of Cyramza, there are now five targeted therapies for hepatocellular carcinoma.
Those with hepatitis B experience greater liver disease progression if they are coinfected with hepatitis C, while HBV does not appear to wors...
Chronic hepatitis B virus (HBV) infection almost doubles the risk of AIDS or death in people diagnosed with HIV infection, compared with those...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.